A breakthrough study by Irish researchers pinpointed a biomarker for the early identification of the potentially deadly ...

A breakthrough study presented at ESCMID Global 2025 highlights IL-6 as a highly accurate early biomarker for sepsis.

A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient ...

A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic ...

Cachexia not only contributes to reduced quality of life but also limits a patient’s ability to tolerate or benefit from standard treatments.

Here, we discover lysophospholipids as endogenous pannexin activators, using activity-guided fractionation of mouse tissue extracts combined with untargeted metabolomics and electrophysiology. We show ...

The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

CD47-amyloid-β-CD74 signaling is a key driver of adaptive immunosuppression in sepsis, suppressing B cells and impairing ...

Surrozen will focus its Wnt biology expertise and Wnt signal modulation antibody technologies on its ophthalmology programs including development of new treatment options for retinopathies. Other ...

The treatment reduced levels of the inflammatory protein IL-6 and restored healthy neuronal signaling, alleviating memory loss in older mice. These findings open the door to therapies that enhance ...

Il Foglio, Italy’s conservative liberal daily, has embarked on a month-long experiment to demonstrate AI’s impact on journalism and daily life. The four-page broadsheet edition of the newspaper will ...